, , , , , e.a.

Immunotherapy Against Lung Cancer

Emerging Opportunities and Challenges

Specificaties
Paperback, blz. | Engels
Springer Nature Singapore | e druk, 2025
ISBN13: 9789819971435
Rubricering
Springer Nature Singapore e druk, 2025 9789819971435
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

This book provides insight into the various immunotherapeutic approaches for the treatment of lung cancers. The chapters of the book discuss the detailed mechanisms of checkpoint inhibitors, co-stimulatory molecules, drugs working in the immunosuppressive environment, and various vaccines for lung cancer. A chapter of the book explores the recent applications of the oncolytic virus in lung cancer treatment and discusses the potential and direction of oncolytic virus-based therapeutic vaccines. The chapter also elucidates the current understanding of the role of Toll-Like Receptors (TLRs) in tumor progression, and the recent progress in utilizing TLR agonists as potential therapeutic agents in lung cancer treatment. Towards the end, the book reviews the applications of stereotactic body radiation therapy (SBRT) and immunotherapy for the treatment of lung cancer. This book provides useful information to a range of audiences including clinical researchers working in the field of lung cancer, and undergraduate and postgraduate students from various disciplines such as pharmacy, microbiology, immunology, pharmacology, biotechnology, and health sciences.

Specificaties

ISBN13:9789819971435
Taal:Engels
Bindwijze:paperback
Uitgever:Springer Nature Singapore

Inhoudsopgave

<p><strong>Chapter 1_</strong>An introduction to Lung cancer.- <strong>Chapter 2_</strong>Immunobiology of Lung cancer.- <strong>Chapter 3_</strong>Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy.- <strong>Chapter 4_</strong>Recent advances in the immunotherapy of Lung cancer.- <strong>Chapter 5_</strong>PD-1/PD-L1 inhibitors for the treatment of Lung cancer.- <strong>Chapter 6_</strong>CTLA-4 inhibitors for the treatment of Lung cancer.- <strong>Chapter 7_</strong>Adoptive T cell therapy for the treatment of Lung cancer.- <strong>Chapter 8_</strong>LAG-3 inhibitors for the treatment of Lung cancer.- <strong>Chapter 9_</strong>IDO and TGF-β inhibitors for the treatment of Lung cancer.- <strong>Chapter 10_</strong>OX40 and CD40 agonists for the treatment of Lung cancer.- <strong>Chapter 11_</strong>ICOS and GITR agonists for the treatment of Lung cancer.- <strong>Chapter 12_</strong>Vaccines and oncolytic virus for the treatment of Lung cancer.-<strong>Chapter 13_</strong>Targeting Toll-like receptors for the treatment of Lung cancer.- <strong>Chapter 14_</strong>Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy.- <strong>Chapter 15_</strong>Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer.- <strong>Chapter 16_</strong>Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer.- <strong>Chapter 17_</strong>Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer.- <strong>Chapter 18_</strong>Insight on the clinical trials of immunotherapy for the treatment of Lung cancer.- <strong>Chapter 19_</strong>Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer.</p><p></p>

Rubrieken

Populaire producten

    Personen

      Trefwoorden

        Immunotherapy Against Lung Cancer